Welcome to our dedicated page for IB Acquisition SEC filings (Ticker: IBACR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on IB Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into IB Acquisition's regulatory disclosures and financial reporting.
IB Acquisition Corp. (IBAC) announced multiple financing arrangements and amendments related to its pending business combination with GNQ Insilico Inc. The company entered into an Equity Purchase Facility giving it the right to sell up to $50.0 million of Class A common stock to an institutional investor over a commitment period of up to 36 months, subject to a 4.99%–9.99% beneficial ownership cap and a 19.99% exchange cap unless stockholders approve more. As consideration, IB Acquisition will issue a $675,000 convertible commitment note.
The company, GNQ and a buyer also signed a Securities Purchase Agreement for senior secured convertible notes, with an initial closing of $16,470,588 in principal and potential additional closings up to $90,000,000. These PIPE Notes bear 12% interest (increasing to 18% upon default), mature in 12 months, are convertible at an initial price of $10.00 per share, and are secured by a first-priority lien on substantially all personal property of IB Acquisition and its subsidiaries. An amendment to the Business Combination Agreement removes the minimum cash closing condition, requires outstanding bridge financing to roll into notes under this structure, and provides for the issuance of 350,000 Class A shares to the buyer, while releasing 610,500 sponsor private placement units from a six‑month lock‑up.
IB Acquisition Corp. (IBAC) is asking stockholders to approve several changes that would give the company more time to complete its initial business combination and avoid an automatic wind‑up. The main proposal extends the business‑combination deadline by six months, from September 28, 2026 to March 28, 2027, by amending the charter; this requires approval by holders of at least 65% of outstanding common shares, including Founder Shares.
A second proposal amends the Investment Management Trust Agreement so the Trust Account terms match the new deadline, and a third allows adjournment of the meeting if more time is needed to solicit votes. Public stockholders may redeem their shares in connection with the extension for cash equal to their pro rata share of the Trust Account, which held approximately $8.3 million as of the record date, implying an expected redemption price of about $10.93 per share. If the extension is not approved and no business combination closes by September 28, 2026, IB Acquisition must redeem 100% of public shares from the Trust Account and then dissolve, leaving only liquidation value and no future upside from any potential transaction.
IB Acquisition Corp., a SPAC, reported a net loss of $567,166 for the quarter and $1,265,934 for the nine months ended June 30, 2026, compared with income in the prior-year periods. General and administrative expenses rose sharply while interest income from the Trust Account declined.
Cash and investments in the Trust Account were $8,261,479 and cash outside the trust was only $30,161, with a working capital deficit of $2,190,878. Management disclosed substantial doubt about the company’s ability to continue as a going concern.
The company has entered into a Business Combination Agreement with GNQ Insilico Inc., supported by shareholder and sponsor agreements and a bridge financing structure of up to $2,000,000, including an initial $250,000 10% secured convertible note and accompanying warrants. Large stockholder redemptions removed approximately $106.1 million and $7.9 million from the Trust Account in two extension votes, leaving 759,139 public shares subject to redemption.
IB Acquisition Corp. reported a net loss of $639,866 for the quarter ended March 31, 2026, driven by higher general and administrative expenses of $748,177 and reduced interest income from its trust investments.
The SPAC’s trust account balance fell to $8.19M after significant redemptions, including about $7.9M at roughly $10.78 per share in March 2026. Common stock subject to possible redemption declined to 759,139 shares, while 4,249,090 non‑redeemable shares remained outstanding.
IB Acquisition entered into a Business Combination Agreement with GNQ Insilico Inc. and arranged up to $2.0M of 10% secured convertible bridge financing to support GNQ ahead of closing. Management disclosed only $4,634 of cash outside the trust and a working capital deficit of $1.55M, concluding these conditions raise substantial doubt about the company’s ability to continue as a going concern absent a successful merger.
IB Acquisition Corp. schedule amendment shows AQR Capital Management, LLC, AQR Capital Management Holdings, LLC and AQR Arbitrage, LLC report 0 shares beneficially owned of common stock, representing 0% of the class as of 03/31/2026. The filing lists issuer address and identifies parent/subsidiary relationships; it is signed and dated 04/08/2026.
IB Acquisition Corp. obtained stockholder approval to extend the deadline to complete its initial business combination from March 28, 2026 to September 28, 2026 through amendments to its trust agreement and articles of incorporation. If no deal is completed by September 28, 2026, the trust account will be liquidated under specified redemption and liquidation procedures, with no trust amounts used to pay dissolution expenses. The changes also clarify that trust funds generally remain locked except for interest used to pay franchise and income taxes, and reinforce public stockholders’ rights to redeem their shares in connection with key charter amendments affecting redemptions or the business combination timeline.
IB Acquisition Corp. reported the results of a special stockholder meeting and related redemptions of its common stock. Stockholders owning 5,077,821 shares, or about 88.46% of shares outstanding as of the February 11, 2026 record date, were present or represented by proxy.
Each proposal voted on at the meeting received 5,007,821 votes for and 70,000 against, with no abstentions or broker non-votes, so all proposals were approved. Separately, holders of 731,741 shares chose to redeem their shares for cash at approximately $10.78 per share from the company’s trust account.
These redemptions will remove about $7.9 million from the trust account, leaving approximately $8.2 million remaining. The remaining trust balance may change to reflect tax withdrawals.
AQR-affiliated investment funds reported open-market sales of IB Acquisition Corp. common stock. On March 23, 2026, entities managed by AQR Capital Management sold a combined 335,000 shares of common stock at $10.80 per share.
The transactions were executed across multiple vehicles, including AQR Global Alternative Investment Offshore Fund, L.P., which held 143,785 shares after its sale, and other funds such as AQR Diversified Arbitrage Fund and several AQR arbitrage and UCITS funds. The sales are reported by AQR Capital Management Holdings, LLC, AQR Capital Management, LLC, and AQR Arbitrage LLC as indirect holdings of ten percent owners.
AQR-related investment entities reported an open-market sale of IB Acquisition Corp. common stock. An account identified as AQR DELTA Master Account, L.P. sold 4,619 shares of common stock on 2026-03-20 at $10.75 per share in an indirect transaction. After this sale, that indirect account held 0 shares of IB Acquisition Corp.
IB Acquisition Corp. reports that its prospective merger partner, GNQ Insilico Inc., has entered a Joint Initiative Agreement and Joint Marketing Attachment with a Fortune 100 global technology company. The two-year, non-exclusive collaboration will jointly market AI-driven drug discovery and precision medicine solutions worldwide, combining GNQ’s proprietary AI platforms with the partner’s consulting, cloud, and quantum computing capabilities.
The report also reiterates a proposed business combination between IB Acquisition and GNQ. IB Acquisition plans to file a Form S-4 registration statement with the SEC, including a joint proxy statement/prospectus that will be sent to its stockholders in connection with the transaction.